- Home
- ALGS vs VRCA Comparison
ALGS vs VRCA Comparison
Compare ALGS & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- VRCA
- Stock Information
- Founded
- ALGS 2018
- VRCA 2013
- Country
- ALGS United States
- VRCA United States
- Employees
- ALGS N/A
- VRCA N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- ALGS Health Care
- VRCA Health Care
- Exchange
- ALGS Nasdaq
- VRCA Nasdaq
- Market Cap
- ALGS 53.0M
- VRCA 58.7M
- IPO Year
- ALGS 2020
- VRCA 2018
- Fundamental
- Price
- ALGS $9.99
- VRCA $4.04
- Analyst Decision
- ALGS Strong Buy
- VRCA Hold
- Analyst Count
- ALGS 2
- VRCA 5
- Target Price
- ALGS $60.00
- VRCA $60.00
- AVG Volume (30 Days)
- ALGS 71.7K
- VRCA 43.2K
- Earning Date
- ALGS 11-05-2025
- VRCA 11-03-2025
- Dividend Yield
- ALGS N/A
- VRCA N/A
- EPS Growth
- ALGS N/A
- VRCA N/A
- EPS
- ALGS N/A
- VRCA N/A
- Revenue
- ALGS $3,174,000.00
- VRCA $14,704,000.00
- Revenue This Year
- ALGS N/A
- VRCA $332.45
- Revenue Next Year
- ALGS $28.79
- VRCA $12.85
- P/E Ratio
- ALGS N/A
- VRCA N/A
- Revenue Growth
- ALGS N/A
- VRCA 5.72
- 52 Week Low
- ALGS $3.76
- VRCA $3.82
- 52 Week High
- ALGS $46.80
- VRCA $20.01
- Technical
- Relative Strength Index (RSI)
- ALGS 51.70
- VRCA 25.92
- Support Level
- ALGS $8.90
- VRCA $4.35
- Resistance Level
- ALGS $11.65
- VRCA $5.23
- Average True Range (ATR)
- ALGS 0.76
- VRCA 0.38
- MACD
- ALGS -0.25
- VRCA -0.08
- Stochastic Oscillator
- ALGS 39.64
- VRCA 4.47
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.